Company

Riva Therapeutics

Riva Therapeutics develops precision oncology medicines for cancer patients.

About

Riva Therapeutics develops small molecule therapies targeting essential tumor cell processes. Its research draws on genomic dependencies in cancer. Founded in 2022, the company is based in San Diego, US. It raised approximately USD 3 million in series A funding in June 2023, led by Forward Equity Partners and Meritz Securities.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in